TP53 and undifferentiated pleomorphic sarcoma: Leiomyosarcomas, undifferentiated pleomorphic sarcomas, and primitive neuro-ectodermic tumors were the tumors most frequently altered for TP53 with 20, 5, and 6 mutations, respectively (Table S2).